Abstract:Background: Hand, foot and mouth disease (HFMD) is caused by members of the family Picornaviridae in the genus Enterovirus. It has been reported that coxsackievirus A6 (CVA6) infections are emerging as a new and major cause of epidemic HFMD. Sporadic HFMD cases positive for CVA6 were detected in the mainland of China in recent years. To strengthen the surveillance of CVA6 infections and outbreak control, the clinical diagnosis is urgently needed to distinguish the CVA6 infection disease from other infections.Methods: In order to develop a sensitive quantitative real-time RT-PCR assay for rapid detection of CVA6 RNA, primers and probe were designed to target the VP1 gene segment of CVA6. The conservation of the target segment was firstly analyzed by bioinformatic technology. The specificity of the real-time RT-PCR was further confirmed by detecting other related viruses and standard curves were established for the sensitivity evaluation. The pharyngeal swab samples from the EV71 and CVA16 unrelated HFMD patients were applied for CVA6 detection through the established method.Results: Based on the primer-probe set to detect the target VP1 gene segment of CVA6, the quantitative real-time RT-PCR assay could discriminate CVA6 infection from other resemble viral diseases with a potential detection limit of 10 viral copies/ml. The specificity of the assay was determined by sequence alignment and experimentally tested on various related viruses. The standard curve showed that the amplification efficiency of templates with different concentrations of templates was almost the same (R-2 > 0.99). Evaluation of the established method with pharyngeal swabs samples showed good accordance with the results from serology diagnosis.Conclusion: This study is the first report developing a VP1 gene-based quantitative real-time RT-PCR for rapid, stable and specific detection of CVA6 virus. The real-time RT-PCR established in this study can be used as a reliable method for early diagnosis of CVA6 infection.

The Development and Characterization of a Stable Coxsackievirus A16 Infectious Clone with Nanoluc Reporter Gene

The Establishment of Infectious Clone and Single Round Infectious Particles for Coxsackievirus A10

Construction and Characterization of an Infectious Clone of Coxsackievirus A6 That Showed High Virulence in Neonatal Mice

Improved Plasmid-Based Recovery of Coxsackievirus A16 Infectious Clone Driven by Human RNA Polymerase I Promoter

A murine model of coxsackievirus A16 infection for anti-viral evaluation

Construction of coxsackievirus B5 viruses with luciferase reporters and their applications in vitro and in vivo

A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge.

Development of a Coxsackievirus A16 Neutralization Test Based on the Enzyme-Linked Immunospot Assay.

Optimization and Characterization of Candidate Strain for Coxsackievirus A16 Inactivated Vaccine

Preparation of the Coxsackievirus A16 VP1 Subunit Vaccine and Detection of Its Immunogenicity

Development of sandwich ELISAs that can distinguish different types of coxsackievirus A16 viral particles

Phenotypic and Genomic Characterization of Human Coxsackievirus A16 Strains with Distinct Virulence in Mice

VP1 Sequence Determination and Phylogenetic Analysis of Coxsackievirus A16 Strains

In Vitro Characterization of Neutralizing Hen Antibodies to Coxsackievirus A16

Comparative analysis of the biological characteristics of three CV‐A10 clones adaptively cultured on Vero cells

Engineering infectious foot-and-mouth disease virus in vivo from a full-length genomic cDNA clone of the A/AKT/58 strain

Identification of a nucleotide in 5′ untranslated region contributing to virus replication and virulence of Coxsackievirus A16

Rapid and Sensitive Identification of RNA from the Emerging Pathogen, Coxsackievirus A6

Protection from Lethal Challenge in a Neonatal Mouse Model by Circulating Recombinant Form Coxsackievirus A16 Vaccine Candidates

Development and characterization of a recombinant Senecavirus A expressing enhanced green fluorescent protein

Replication Kinetics of Coxsackievirus A16 in Human Rhabdomyosarcoma Cells